Moderna COVID-19 vaccine: Continued monitoring
At the time of authorization, no major safety concerns have been reported in the available data submitted to Health Canada. We are carefully monitoring the post-market (after authorization) safety and effectiveness of authorized COVID-19 vaccines. As part of our commitment to keep Canadians informed, we are publishing information about adverse events following immunization (AEFI).
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Moderna COVID-19 vaccine: Continued monitoringHTMLEnglish publication HTML
-
Moderna COVID-19 vaccine: Continued monitoringHTMLFrench publication HTML
Similar records